Opinion: Tales from the Nonacademic Career Path

Graduate students from The Scripps Research Institute share how they prepared to enter policy, law, biotech, and beyond.

Written byAnna Kriebs
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISTOCK, BAONAOver the last month, I have been on a quest: To find out how those of us scientists searching for jobs outside academia were faring and if my own experience in looking beyond the ivory tower was an outlier or a representative measurement. As I was preparing to leave The Scripps Research Institute (TSRI), where I had been a graduate student for the past five years, I wanted to understand why transitioning into a non-academic career could feel like taking the road less traveled, when it is, in fact, the path of most graduate students at TSRI and elsewhere.

Trained in biochemistry, I focused my graduate research on understanding time-of-day dependent metabolic fluctuations. Post-graduation, I was looking for a career that would draw on my experience but allow me to delve into a broader range of scientific discoveries. Thus, I became interested in science communication. In my current job search I am ruling out post-doctoral training.

Non-academic positions require applicants to pair their scientific knowledge and competence acquired during academic training with additional skills. Naturally, different non-academic career paths demand vastly different qualifications, the only commonality being the need to plan ahead. For instance, my former classmate Alex Krois, who earned his PhD in a structural biology lab, intends to work as a biotech-IP lawyer. He spent three months prepping for the Law School ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies